GENEVA, July 31 -- PHARMAESSENTIA CORPORATION filed a patent application (US2025/050340) for “COMPOSITION AND METHOD OF TREATING HUMAN T CELL LYMPHOTROPIC VIRUS ASSOCIATED DISEASE”. With publication no. WO/2026/084962, here are the other details related to the patent application:
Kind: Later publication of revised version of international search report [A9]
IPC: A61K 47/60
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....